We are measuring the size of lesions in Generalized Bullous Fixed Drug Eruption compared to those in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to better differentiate the two diagnoses.
Thank you for your interest, but this study is recruiting by invitation only.
North Carolina (Statewide)
Rachel Blasiak
Dermatology
Clinical or Medical
Observational
Skin, Hair, and Nails
22-0536
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
